OFG
CSTL icon

Oxford Financial Group’s Castle Biosciences CSTL Stock Holding History

Oxford Financial Group’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,394
Closed -$362K – 224
2020
Q4 		$362K Sell
5,394
-81,326
-94% -$4.41M 0.05% 133
2020
Q3 		$4.46M Hold
86,720
– – 0.72% 23
2020
Q2 		$3.27M Buy
86,720
+68,924
+387% +$2.35M 0.55% 28
2020
Q1 		$530K Buy
+17,796
New +$537K 0.11% 82

Other funds holding CSTL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $691M AUM 27.96% 1-Year Est. Return

Oxford Financial Group's CSTL Position: Q1 2021 in Review

Oxford Financial Group sold out of Castle Biosciences (CSTL) in Q1 2021, closing a stake of 5,394 shares — an estimated $362K sold.

Oxford Financial Group first reported a position in CSTL in Q1 2020 and held it in 4 quarters. The position peaked at $4.46M in Q3 2020. 175 funds tracked by Wall St. Rank hold CSTL as of Q1 2021.

  • Oxford Financial Group reported no remaining Castle Biosciences position as of Q1 2021 after selling out during the quarter.
  • Oxford Financial Group sold 5,394 Castle Biosciences shares in Q1 2021, an estimated $362K.
  • Oxford Financial Group first reported a position in Castle Biosciences in Q1 2020 and held it in 4 quarters.
  • Oxford Financial Group's Castle Biosciences position peaked at $4.46M in Q3 2020.
  • 175 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2021.

Based on Oxford Financial Group's 13F filing for Q1 2021, filed 10 May 2021.